Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!

Biomarker Services (CAT#: STEM-MB-0247-WXH)

Introduction

MSD offers a comprehensive service to screen, select, and validate custom biomarker tests. With over twenty years of experience in developing and multiplexing high-quality commercial immunoassays, MSD can accelerate your biomarker program from early stage discovery to the production of fully validated assays.
A broad range of biomarkers can be screened, and the relevant biomarkers can then be translated to focused panels and validated for your sample testing needs.




Applications

a valuable tool to determine disease progression or how the drug exerts its effects in terms of safety or efficacy.
Cytokine Storm Assays to Assess Risk of Cytokine Release Syndrome
Biomarker Screening and Identification for Patient Stratification and Companion Diagnostics
Phosphorylation, Biomarker, and Analyte Determinations of Clinically Relevant Signaling Pathways
Toll-Like Receptor Panels for Infectious, Inflammatory or Neoplastic Disease
T-cell Function, T-cell Receptor, and Macrophage/Monocyte Panels for Immunomodulatory and Infective Diseases
Functional Stimulator of Interferon Gene (STING) Assays for Evaluating Pleiotropic Pathway Modulation
Platform for 3D Polycystic Kidney Disease Assays
Assays and Platforms using Human Taste Bud Epithelial Cells

Procedure

Infectious diseases and cancer along with other diseases are mostly diagnosed by biomarker detection in laboratories using conventional tests such as enzyme linked immunosorbent assay (ELISA), immunofluorescence, western blotting, immunodiffusion, polymerase chain reaction (PCR), flow cytometry and a wide range of other techniques
Advertisement